RBM3 and cancer: Accordingly, high nuclear (and in some cases cytosolic) expression of RBM3 is associated with improved disease free and overall survival in a wide range of cancers, including: melanoma, breast, prostate, epithelial ovarian, testicular, colorectal, urothelial bladder, esophageal and gastric, and astrocytoma29,89–96.